SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
GRCE

Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD
Healthcare · Biotechnology
1.77-0.16 (-8.29%)
 
Market cap
$28.8M
Insider Score
Analyst consensus
Insider Score
/ 100
GRCE Insider Score

Grace Therapeutics, Inc. has a live Insider Score.

Scored on 1 qualifying trade from 1 insider in the last 90 days.

Unlock the score

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

GRCE Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New GRCE patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to GRCE from public contracts

Source: USAspending.gov

Recently reported changes in GRCE holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing GRCE, reported under the STOCK Act.

PoliticianChamberActionAmountDate
No congressional trades recorded for GRCE.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.